These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22131693)

  • 21. Kala-azar epidemic in Varanasi district, India.
    Kumar R; Kumar P; Chowdhary RK; Pai K; Mishra CP; Kumar K; Pandey HP; Singh VP; Sundar S
    Bull World Health Organ; 1999; 77(5):371-4. PubMed ID: 10361752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study on delay in treatment of kala-azar patients in Bangladesh.
    Arif SM; Basher A; Rahman MR; Faiz MA
    WHO South East Asia J Public Health; 2012; 1(4):396-403. PubMed ID: 28615604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "
    Sunyoto T; Adam GK; Atia AM; Hamid Y; Babiker RA; Abdelrahman N; Vander Kelen C; Ritmeijer K; Alcoba G; den Boer M; Picado A; Boelaert M
    Am J Trop Med Hyg; 2018 Apr; 98(4):1091-1101. PubMed ID: 29488462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Awareness about kala-azar disease and related preventive attitudes and practices in a highly endemic rural area of India.
    Siddiqui NA; Kumar N; Ranjan A; Pandey K; Das VN; Verma RB; Das P
    Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):1-12. PubMed ID: 20578475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A DNA microarray-based analysis of immune-stimulatory and transcriptional responses of dendritic cells to KALA-modified nanoparticles.
    Akita H; Ishii S; Miura N; Shaheen SM; Hayashi Y; Nakamura T; Kaji N; Baba Y; Harashima H
    Biomaterials; 2013 Nov; 34(35):8979-90. PubMed ID: 23968857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar.
    Pampiglione S; Manson-Bahr PE; La Placa M; Borgatti MA; Musumeci S
    Trans R Soc Trop Med Hyg; 1975; 69(1):60-8. PubMed ID: 1145719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized open-label comparative clinical study of effect of lifestyle modification and
    Deshmukh S; Vyas MK; Dwivedi RR; Vyas HA
    Ayu; 2016; 37(1):45-55. PubMed ID: 28827955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Observations on Vamana procedure in healthy volunteers.
    Gupta B; Mahapatra SC; Makhija R; Kumar A; Jirankalgikar N; Padhi MM; Devalla RB
    Ayu; 2011 Jan; 32(1):40-5. PubMed ID: 22131756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectrum of skin lesions of post-kala-azar dermal leishmaniasis in kala-azar endemic areas of Bangladesh.
    Sultana A; Zakaria SM; Bhuiyan SI; Habib A; Dey SK; Rahman M; Basher A
    Mymensingh Med J; 2012 Jul; 21(3):529-32. PubMed ID: 22828555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of kala-azar surveillance in Gaffargaon subdistrict of Mymensingh, Bangladesh.
    Rahman KM; Samarawickrema IV; Harley D; Olsen A; Butler CD; Sumon SA; Biswas SK; Luby SP; Sleigh AC
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003531. PubMed ID: 25860258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiological characteristics of Kala-azar disease in China, during 2005-2015].
    Zheng CJ; Xue CZ; Wu WP; Zhou XN
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr; 38(4):431-434. PubMed ID: 28468057
    [No Abstract]   [Full Text] [Related]  

  • 34. Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar.
    Zijlstra EE; el-Hassan AM
    Trans R Soc Trop Med Hyg; 1993; 87(4):425-7. PubMed ID: 8249072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnitude of unreported kala-azar cases in a highly endemic district of Bihar, India: A positive impact of Indian elimination programme.
    Siddiqui NA; Pandey K; R Das VN; Sinha SK; Verma RB; Lal CS; Ali V; Topno RK; Dikhit MR; Das P
    J Vector Borne Dis; 2019; 56(4):315-322. PubMed ID: 33269731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatial and temporal variation and hotspot detection of kala-azar disease in Vaishali district (Bihar), India.
    Bhunia GS; Kesari S; Chatterjee N; Kumar V; Das P
    BMC Infect Dis; 2013 Feb; 13():64. PubMed ID: 23375077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infectivity of Post-Kala-azar Dermal Leishmaniasis Patients to Sand Flies: Revisiting a Proof of Concept in the Context of the Kala-azar Elimination Program in the Indian Subcontinent.
    Molina R; Ghosh D; Carrillo E; Monnerat S; Bern C; Mondal D; Alvar J
    Clin Infect Dis; 2017 Jul; 65(1):150-153. PubMed ID: 28520851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroepidemiological study on kala-azar in Baringo District, Kenya.
    Jahn A; Lelmett JM; Diesfeld HJ
    J Trop Med Hyg; 1986 Apr; 89(2):91-104. PubMed ID: 3021967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis.
    Zijlstra EE; el-Hassan AM; Ismael A; Ghalib HW
    Am J Trop Med Hyg; 1994 Dec; 51(6):826-36. PubMed ID: 7810819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PCR for diagnosis and assessment of cure in kala-azar patients in Bangladesh.
    Salam MA; Mondal D; Kabir M; Ekram AR; Haque R
    Acta Trop; 2010 Jan; 113(1):52-5. PubMed ID: 19769932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.